Medical Educational Resource
Limb-Girdle Muscular Dystrophy and the Diagnostic Odyssey
Activity Snapshot
This program is supported in part by an independent educational grant from Sarepta Therapeutics
Faculty
Matthew Wicklund from University of Colorado Medicine provides an overview of distinguishing clinical and genetic features of the major subtypes of limb-girdle muscular dystrophy (LGMD) and the currently available diagnostic tests for identification of the various LGMD subtypes. The webinar provides practical guidance on the optimal workflow to obtain a definitive diagnosis, as well as a discussion of how an accurate diagnosis helps to inform the management plan.
- Identify the different limb-girdle muscular dystrophy (LGMD) subtypes, including the genetic and pathophysiologic differences
- Understanding the importance of obtaining a definitive genetic diagnosis
- Understand the role of multidisciplinary care in optimizing treatment outcomes
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of PeerPoint Medical Education Institute, LLC and the Muscular Dystrophy Association. The PeerPoint Medical Education Institute, LLC is accredited by the ACCME to provide continuing medical education for physicians.
The PeerPoint Medical Education Institute, LLC designates this live activity for a maximum of .75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
March 15, 2021 - March 15, 2024
Once you have viewed the program, MDA will share back with you instructions for how to obtain your CME credits. If you have questions on this process, please reach out to cmemanagement@mdausa.org.
The following presenters, planners, editors, or staff have relevant financial relationships to disclose:
"I, or an immediate family member, have at present or have had within the last 12 months, the following affiliation with one or more organizations that could be perceived as a real or apparent conflict of interest in context to the design, implementation, presentation, evaluation, etc. of CME Activities."
Name: Matthew Paul Wicklund
Commercial Interest: Affinia Therapeutics
For what role?: Consulting
What was received?: Consulting fees
Commercial Interest: Amicus Therapeutics
For what role?: Consulting
What was received?: Consulting fees
Commercial Interest: ML Bio Solutions
For what role?: Consulting
What was received?: Consulting fees
Commercial Interest: Sarepta Therapeutics
For what role?: Consulting and research funding
What was received?: Consulting fees
All other presenters, planners, editors, or staff reported no relevant relationships with the following statement:
"I, or an immediate family member, do not have at present, or within the last 12 months, nor anticipate having financial interest, arrangement or affiliation with any organizations that could be perceived as a real or apparent conflict of interest in context to the design, implementation, presentation, evaluation, etc. of CME Activities."